A 77-year-old woman, who tested positive on March 21, died at Guam Regional Medical City on June 9. She was Guam's 367th Covid-related fatality. The patient was fully vaccinated with one booster and had underlying health conditions.
Today, the Department of Public Health and Social Services (DPHSS) reported 61 new cases of COVID-19 from 457 specimens collected June 8. 13 of the cases reported today are through the Department of Defense. To date, there have been a total of 49,779 officially reported cases, 367 deaths, 480 cases in active isolation, and 48,932 not in active isolation.
Earlier this year, DPHSS issued a standing order for a Covid-19 therapeutic called Paxlovid. Paxlovid was given emergency use authorization by the U.S. Food and Drug Administration for the treatment of Covid-19. Treatment is indicated for recently diagnosed Covid-19 patients with mild-moderate symptoms. To avail of the Covid-19 oral pill therapeutic, eligible patients must consult with their physicians. Prescribing providers are advised to document SARS-CoV-2 viral test (lab-based antigen or PCR), and symptoms of COVID-19 for ≤5 days.
Due to limited available supplies, prescribing physicians are advised to risk stratify based on the following criteria:
Highest Priority: ● Not fully vaccinated; and
● Over the age of 50; and
● Has one or more comorbidities associated with increased risk of severe illness, hospitalization, or death referenced in
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical -conditions.html; or
● Fully vaccinated: and
● Over the age of 65; and
● Has two or more comorbidities associated with increased risk of severe illness, hospitalization, or death referenced in https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical -conditions.html.